FXR: a metabolic regulator and cell protector
Top Cited Papers
- 30 September 2008
- journal article
- review article
- Published by Springer Nature in Cell Research
- Vol. 18 (11), 1087-1095
- https://doi.org/10.1038/cr.2008.289
Abstract
Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily of ligand-activated transcription factors. As a metabolic regulator, FXR plays key roles in bile acid, cholesterol, lipid, and glucose metabolism. Therefore, FXR is a potential drug target for a number of metabolic disorders, especially those related to the metabolic syndrome. More recently, our group and others have extended the functions of FXR to more than metabolic regulation, which include anti-bacterial growth in intestine, liver regeneration, and hepatocarcinogenesis. These new findings suggest that FXR has much broader roles than previously thought, and also highlight FXR as a drug target for multiple diseases. This review summarizes the basic information of FXR but focuses on its new functions.Keywords
This publication has 81 references indexed in Scilit:
- FXR signaling in metabolic diseaseFEBS Letters, 2007
- The farnesoid X receptor FXRα/NR1H4 acquired ligand specificity for bile salts late in vertebrate evolutionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activationBreast Cancer Research and Treatment, 2007
- Spontaneous hepatocarcinogenesis in farnesoid X receptor-null miceCarcinogenesis: Integrative Cancer Research, 2006
- Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activationProceedings of the National Academy of Sciences, 2006
- Nuclear factor-κB in cancer development and progressionNature, 2006
- The farnesoid X receptor induces very low density lipoprotein receptor gene expressionFEBS Letters, 2004
- Liver regenerationJournal of Hepatology, 2000
- Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiencyJournal of Hepatology, 1994
- Glycogen storage disease I and hepatocellular tumoursEuropean Journal of Pediatrics, 1993